Epoxyeicosanoid signaling in CNS function and disease

Jeffrey Iliff, Jia Jia, Jonathan Nelson, Toru Goyagi, Judy Klaus, Nabil Alkayed

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites of cytochrome P450 epoxygenase enzymes recognized as key players in vascular function and disease, primarily attributed to their potent vasodilator, anti-inflammatory and pro-angiogenic effects. Although EETs' actions in the central nervous system (CNS) appear to parallel those in peripheral tissue, accumulating evidence suggests that epoxyeicosanoid signaling plays different roles in neural tissue compared to peripheral tissue; roles that reflect distinct CNS functions, cellular makeup and intercellular relationships. This is exhibited at many levels including the expression of EETs-synthetic and -metabolic enzymes in central neurons and glial cells, EETs' role in neuro-glio-vascular coupling during cortical functional activation, the capacity for interaction between epoxyeicosanoid and neuroactive endocannabinoid signaling pathways, and the regulation of neurohormone and neuropeptide release by endogenous EETs. The ability of several CNS cell types to produce and respond to EETs suggests that epoxyeicosanoid signaling is a key integrator of cell-cell communication in the CNS, coordinating cellular responses across different cell types. Under pathophysiological conditions, such as cerebral ischemia, EETs protect neurons, astroglia and vascular endothelium, thus preserving the integrity of cellular networks unique to and essential for proper CNS function. Recognition of EETs' intimate involvement in CNS function in addition to their multi-cellular protective profile has inspired the development of therapeutic strategies against CNS diseases such as cerebral ischemia, tumors, and neural pain and inflammation that are based on targeting the cellular actions of EETs or their biosynthetic and metabolizing enzymes. Based upon the emerging importance of epoxyeicosanoids in cellular function and disease unique to neural systems, we propose that the actions of "neuroactive EETs" are best considered separately, and not in aggregate with all other peripheral EETs functions.

Original languageEnglish (US)
Pages (from-to)68-84
Number of pages17
JournalProstaglandins and Other Lipid Mediators
Volume91
Issue number3-4
DOIs
StatePublished - Apr 2010

Fingerprint

Central Nervous System Diseases
Neurology
Central Nervous System
Brain Ischemia
Cytochrome P-450 Enzyme System
Tissue
Neurons
Endocannabinoids
Aptitude
Vascular Endothelium
Enzymes
Neuropeptides
Vasodilator Agents
Vascular Diseases
Arachidonic Acid
Cell Communication
Neuroglia
Astrocytes
Neurotransmitter Agents
Blood Vessels

Keywords

  • 2C11
  • Astrocytes
  • Cytochrome P450
  • Endothelium
  • EPHX2
  • Epoxyeicosanoids
  • Epoxyeicosatrienoic acids (EETs)
  • Epoxygenase
  • Functional hyperemia
  • Ischemia
  • Neuro-inflammation
  • Neurovascular coupling
  • Pain
  • Soluble epoxide hydrolase
  • Stroke

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Pharmacology
  • Cell Biology

Cite this

Epoxyeicosanoid signaling in CNS function and disease. / Iliff, Jeffrey; Jia, Jia; Nelson, Jonathan; Goyagi, Toru; Klaus, Judy; Alkayed, Nabil.

In: Prostaglandins and Other Lipid Mediators, Vol. 91, No. 3-4, 04.2010, p. 68-84.

Research output: Contribution to journalArticle

Iliff, Jeffrey ; Jia, Jia ; Nelson, Jonathan ; Goyagi, Toru ; Klaus, Judy ; Alkayed, Nabil. / Epoxyeicosanoid signaling in CNS function and disease. In: Prostaglandins and Other Lipid Mediators. 2010 ; Vol. 91, No. 3-4. pp. 68-84.
@article{6cdc3cc2ac854fe5891bc855f0644b75,
title = "Epoxyeicosanoid signaling in CNS function and disease",
abstract = "Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites of cytochrome P450 epoxygenase enzymes recognized as key players in vascular function and disease, primarily attributed to their potent vasodilator, anti-inflammatory and pro-angiogenic effects. Although EETs' actions in the central nervous system (CNS) appear to parallel those in peripheral tissue, accumulating evidence suggests that epoxyeicosanoid signaling plays different roles in neural tissue compared to peripheral tissue; roles that reflect distinct CNS functions, cellular makeup and intercellular relationships. This is exhibited at many levels including the expression of EETs-synthetic and -metabolic enzymes in central neurons and glial cells, EETs' role in neuro-glio-vascular coupling during cortical functional activation, the capacity for interaction between epoxyeicosanoid and neuroactive endocannabinoid signaling pathways, and the regulation of neurohormone and neuropeptide release by endogenous EETs. The ability of several CNS cell types to produce and respond to EETs suggests that epoxyeicosanoid signaling is a key integrator of cell-cell communication in the CNS, coordinating cellular responses across different cell types. Under pathophysiological conditions, such as cerebral ischemia, EETs protect neurons, astroglia and vascular endothelium, thus preserving the integrity of cellular networks unique to and essential for proper CNS function. Recognition of EETs' intimate involvement in CNS function in addition to their multi-cellular protective profile has inspired the development of therapeutic strategies against CNS diseases such as cerebral ischemia, tumors, and neural pain and inflammation that are based on targeting the cellular actions of EETs or their biosynthetic and metabolizing enzymes. Based upon the emerging importance of epoxyeicosanoids in cellular function and disease unique to neural systems, we propose that the actions of {"}neuroactive EETs{"} are best considered separately, and not in aggregate with all other peripheral EETs functions.",
keywords = "2C11, Astrocytes, Cytochrome P450, Endothelium, EPHX2, Epoxyeicosanoids, Epoxyeicosatrienoic acids (EETs), Epoxygenase, Functional hyperemia, Ischemia, Neuro-inflammation, Neurovascular coupling, Pain, Soluble epoxide hydrolase, Stroke",
author = "Jeffrey Iliff and Jia Jia and Jonathan Nelson and Toru Goyagi and Judy Klaus and Nabil Alkayed",
year = "2010",
month = "4",
doi = "10.1016/j.prostaglandins.2009.06.004",
language = "English (US)",
volume = "91",
pages = "68--84",
journal = "Prostaglandins and Other Lipid Mediators",
issn = "1098-8823",
publisher = "Elsevier Inc.",
number = "3-4",

}

TY - JOUR

T1 - Epoxyeicosanoid signaling in CNS function and disease

AU - Iliff, Jeffrey

AU - Jia, Jia

AU - Nelson, Jonathan

AU - Goyagi, Toru

AU - Klaus, Judy

AU - Alkayed, Nabil

PY - 2010/4

Y1 - 2010/4

N2 - Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites of cytochrome P450 epoxygenase enzymes recognized as key players in vascular function and disease, primarily attributed to their potent vasodilator, anti-inflammatory and pro-angiogenic effects. Although EETs' actions in the central nervous system (CNS) appear to parallel those in peripheral tissue, accumulating evidence suggests that epoxyeicosanoid signaling plays different roles in neural tissue compared to peripheral tissue; roles that reflect distinct CNS functions, cellular makeup and intercellular relationships. This is exhibited at many levels including the expression of EETs-synthetic and -metabolic enzymes in central neurons and glial cells, EETs' role in neuro-glio-vascular coupling during cortical functional activation, the capacity for interaction between epoxyeicosanoid and neuroactive endocannabinoid signaling pathways, and the regulation of neurohormone and neuropeptide release by endogenous EETs. The ability of several CNS cell types to produce and respond to EETs suggests that epoxyeicosanoid signaling is a key integrator of cell-cell communication in the CNS, coordinating cellular responses across different cell types. Under pathophysiological conditions, such as cerebral ischemia, EETs protect neurons, astroglia and vascular endothelium, thus preserving the integrity of cellular networks unique to and essential for proper CNS function. Recognition of EETs' intimate involvement in CNS function in addition to their multi-cellular protective profile has inspired the development of therapeutic strategies against CNS diseases such as cerebral ischemia, tumors, and neural pain and inflammation that are based on targeting the cellular actions of EETs or their biosynthetic and metabolizing enzymes. Based upon the emerging importance of epoxyeicosanoids in cellular function and disease unique to neural systems, we propose that the actions of "neuroactive EETs" are best considered separately, and not in aggregate with all other peripheral EETs functions.

AB - Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites of cytochrome P450 epoxygenase enzymes recognized as key players in vascular function and disease, primarily attributed to their potent vasodilator, anti-inflammatory and pro-angiogenic effects. Although EETs' actions in the central nervous system (CNS) appear to parallel those in peripheral tissue, accumulating evidence suggests that epoxyeicosanoid signaling plays different roles in neural tissue compared to peripheral tissue; roles that reflect distinct CNS functions, cellular makeup and intercellular relationships. This is exhibited at many levels including the expression of EETs-synthetic and -metabolic enzymes in central neurons and glial cells, EETs' role in neuro-glio-vascular coupling during cortical functional activation, the capacity for interaction between epoxyeicosanoid and neuroactive endocannabinoid signaling pathways, and the regulation of neurohormone and neuropeptide release by endogenous EETs. The ability of several CNS cell types to produce and respond to EETs suggests that epoxyeicosanoid signaling is a key integrator of cell-cell communication in the CNS, coordinating cellular responses across different cell types. Under pathophysiological conditions, such as cerebral ischemia, EETs protect neurons, astroglia and vascular endothelium, thus preserving the integrity of cellular networks unique to and essential for proper CNS function. Recognition of EETs' intimate involvement in CNS function in addition to their multi-cellular protective profile has inspired the development of therapeutic strategies against CNS diseases such as cerebral ischemia, tumors, and neural pain and inflammation that are based on targeting the cellular actions of EETs or their biosynthetic and metabolizing enzymes. Based upon the emerging importance of epoxyeicosanoids in cellular function and disease unique to neural systems, we propose that the actions of "neuroactive EETs" are best considered separately, and not in aggregate with all other peripheral EETs functions.

KW - 2C11

KW - Astrocytes

KW - Cytochrome P450

KW - Endothelium

KW - EPHX2

KW - Epoxyeicosanoids

KW - Epoxyeicosatrienoic acids (EETs)

KW - Epoxygenase

KW - Functional hyperemia

KW - Ischemia

KW - Neuro-inflammation

KW - Neurovascular coupling

KW - Pain

KW - Soluble epoxide hydrolase

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=77949490789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949490789&partnerID=8YFLogxK

U2 - 10.1016/j.prostaglandins.2009.06.004

DO - 10.1016/j.prostaglandins.2009.06.004

M3 - Article

C2 - 19545642

AN - SCOPUS:77949490789

VL - 91

SP - 68

EP - 84

JO - Prostaglandins and Other Lipid Mediators

JF - Prostaglandins and Other Lipid Mediators

SN - 1098-8823

IS - 3-4

ER -